GENA-111-Multilink-auristatin F ADC (Genome & Co/Debiopharm)

N/A

Report date: 2025/01/26 17:56:51

Base Information

Drug NameGENA-111-Multilink-auristatin F ADC (Genome & Co/Debiopharm)
Drug Alias Nameanti-B-CAM antibody-drug conjugate (Genome & Co/Debiopharm)GENA-111-AF
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionBasal cell adhesion molecule modulators
TargetsBasal cell adhesion molecule
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandSouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDebiopharm Research & Manufacturing SA
China Registration ClassN/A

Develop Information

Active CompaniesGenome & CompanyDebiopharm Research & Manufacturing SA
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A